Zynlonta manufacturer ADC Therapeutics is continuing to prune its pipeline, calling time on its sole clinical-stage candidate after taking a look at the early-stage data. The asset in question ...

That study established the company’s Astellas-partnered Nectin-4 ADC Padcev and Merck & Co.’s PD-1 king Keytruda as the standard first-line bladder cancer treatment in a biomarker-unselective ...

LAUSANNE, Switzerland, April 28, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today ...

Keymed Biosciences Inc., a biotech company focused on the urgent unmet clinical needs, announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) developed by Keymed, received Investigational ...

located in all 50 states and containing approximately 50.3 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol "ADC".

The Analog-to-Digital Converter (ADC) is a key component in digital communications receive channels, and the correct choice of ADC is critical for optimizing system design. In this article, we discuss ...

The 4th World ADC Asia Summit is back, offering the most comprehensive platform for Asia’s rapidly growing ADC community. This summit brings together cutting-edge innovators from Asia alongside ...

Superb internalization profile paired with proprietary linker technology underscore strong efficacy and optimal stability data; first-in-class ADC program currently in IND-enabling studies ...

The phase 1b trial is investigating the ADC and Keytruda – with or without chemo – in both previously-untreated and pretreated patients with advanced NSCLC who don’t have genetic mutations ...

Over the last 14 years, the World ADC team has accompanied the community industry through ups and down while offering the latest insights on how to improve ADC drug development. We take pride in ...